Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
PineTree Therapeutics
company
About
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $23.50M
- Industries
- Biotechnology,Medical,Therapeutics,Wellness
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$23.50M
PineTree Therapeutics has raised a total of
$23.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2022 | Series A | $23.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
PineTree Therapeutics is funded by 2 investors.
SGI Venture Capital
and JCurve Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SGI Venture Capital
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
